Business Development Director, Proteomics
Ian joined Proteome Sciences in November 2002 from Cancer Research Technology, the technology transfer and business development company owned by Cancer Research UK. Ian holds a Ph.D. in medical microbiology from the University of Leeds and ran a research group at Wellcome Diagnostics and subsequently Murex Biotech Ltd. for 8 years. In the four years after Murex he worked in academic technology transfer performing many licensing deals and working on the formation of three biotech start-ups. He has served as a non-executive director on the boards of Spirogen and Proacta Therapeutics, two biotechnology start-ups formed by Cancer Research Ventures and is currently a director of SEHTA, the South East Healthcare Technologies Alliance. As Business Development Director at Proteome Sciences, Ian is responsible for the commercial development of its ProteoSHOP™ toolkit offering a combination of high-throughput and high sensitivity proteomics. Ian is also responsible for general licensing activities and management of the company’s extensive intellectual property portfolio.